Skip to content

Pat Fox Fulgham, M.D.

NPI 1295788206ActiveIndividual· Urology· Dallas, TX

Urology (M.D.) in Dallas, Texas, licensed in TX, with an NPI issued in May 2006. Part D covered 111 prescriptions written in 2024, 97% of them generic. Astrazeneca Pharmaceuticals LP was the largest of 8 companies reporting payments in 2025, $8,482 in all, mostly consulting fees.

Overview

NPI1295788206
StatusActive
Entity typeIndividual
CredentialM.D.
Sole proprietorNo
NPI issuedMay 19, 2006
Last updated in NPPESJan 31, 2017

Specialties and licenses

TaxonomyCodeLicenseState
Urology Primary208800000XF9454TX

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Nov 10, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 11, 2026No match—
New York OMIG · Nov 11, 2026No match—
Ohio Medicaid · Nov 11, 2026No match—
Pennsylvania Medicheck · Nov 11, 2026No match—
Washington HCA · Nov 11, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Enrolled Practitioner - Urology (TX)

Part D prescriptions in 2024

Prescriptions (claims)111 · 286 30-day fills
Patients42
Total drug cost$6,016
Generic share97% of claims

Medicare sources and data years

Industry payments (Open Payments)

  • 2025$8,482 · 20 payments from 8 companies
  • 2024$5,645 · 23 payments from 5 companies

Top paying companies in 2025

What the 2025 payments were for

  • Consulting Fee$7,307 · 5 payments
  • Food and Beverage$1,143 · 14 payments
  • Travel and Lodging$32.13 · 1 payment

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other urologists in Dallas

All 83 urologists in Dallas · All urologists in Texas